• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从携带LRRK2 p.I1371V突变的帕金森病患者中生成诱导多能干细胞(IBMSi011-A)。

Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.

作者信息

Lin Han-I, Cheng Yu-Che, Ko Hui-Wen, Wen Cheng-Hao, Lu Huai-En, Huang Ching-Ying, Hsieh Patrick C H, Lin Chin-Hsien

机构信息

Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan; Institute of Molecular Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.

Institute of Biomedical Science, Academia Sinica, Taipei, Taiwan.

出版信息

Stem Cell Res. 2019 May;37:101447. doi: 10.1016/j.scr.2019.101447. Epub 2019 Apr 22.

DOI:10.1016/j.scr.2019.101447
PMID:31029016
Abstract

Leucine rich repeat kinase 2 (LRRK2) is the causative gene for autosomal-dominant familial forms of Parkinson's disease (PD). Here, we generated induced pluripotent stem cells (iPSCs) from the peripheral blood mononuclear cells of a female patient with LRRK2 c.4111A > G (p.I1371V) mutation by using the Sendai-virus delivery system. The resulting iPSCs had a normal karyotype. The iPSCs also showed pluripotency confirmed by immunofluorescent staining and differentiated into the three germ layers in vivo. This cellular model will provide a platform for studying the role of LRRK2 in the disease process.

摘要

富含亮氨酸重复激酶2(LRRK2)是常染色体显性遗传性帕金森病(PD)的致病基因。在此,我们通过仙台病毒递送系统,从一名携带LRRK2基因c.4111A > G(p.I1371V)突变的女性患者的外周血单核细胞中诱导生成了诱导多能干细胞(iPSC)。所获得的iPSC具有正常的核型。通过免疫荧光染色证实这些iPSC也具有多能性,并能在体内分化为三个胚层。该细胞模型将为研究LRRK2在疾病进程中的作用提供一个平台。

相似文献

1
Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.从携带LRRK2 p.I1371V突变的帕金森病患者中生成诱导多能干细胞(IBMSi011-A)。
Stem Cell Res. 2019 May;37:101447. doi: 10.1016/j.scr.2019.101447. Epub 2019 Apr 22.
2
Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.携带与帕金森病相关的LRRK2变异体S1647T的人诱导多能干细胞(iPSC)系的产生。
Stem Cell Res. 2017 Jan;18:54-56. doi: 10.1016/j.scr.2016.12.010. Epub 2016 Dec 9.
3
Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.从一名携带LRRK2基因R1628P变体的帕金森病患者身上重编程出的人类诱导多能干细胞(iPSC)系。
Stem Cell Res. 2017 Jan;18:45-47. doi: 10.1016/j.scr.2016.12.011. Epub 2016 Dec 10.
4
Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene.从一名早发性帕金森病患者中重编程得到的人诱导多能干细胞(iPSC)系(IBMSi012-A),该患者在PLA2G6基因中存在纯合的p.D331Y突变。
Stem Cell Res. 2019 May;37:101432. doi: 10.1016/j.scr.2019.101432. Epub 2019 Apr 5.
5
Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene.从一名携带LRRK2基因N551K变体的帕金森病患者身上开发人诱导多能干细胞(iPSC)系。
Stem Cell Res. 2017 Jan;18:51-53. doi: 10.1016/j.scr.2016.12.013. Epub 2016 Dec 8.
6
Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease.帕金森病中携带LRRK2基因R1398H变异的人诱导多能干细胞(iPSC)系的衍生
Stem Cell Res. 2017 Jan;18:48-50. doi: 10.1016/j.scr.2016.12.014. Epub 2016 Dec 9.
7
Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation.从携带LRRK2 p.I2012T突变的帕金森病患者中诱导产生多能干细胞。
Stem Cell Res. 2017 Dec;25:123-127. doi: 10.1016/j.scr.2017.10.020. Epub 2017 Oct 31.
8
Generation of induced pluripotent stem cells (NIMHi001-A) from a Parkinson's disease patient of East Indian ethnicity carrying LRRK2 I1371V variant.从一名携带LRRK2 I1371V变异的东印度裔帕金森病患者中生成诱导多能干细胞(NIMHi001-A)。
Stem Cell Res. 2020 Apr;44:101768. doi: 10.1016/j.scr.2020.101768. Epub 2020 Mar 17.
9
Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.源自携带LRRK2 G2385R变异的帕金森病患者的2个诱导多能干细胞系的产生。
Stem Cell Res. 2018 Apr;28:1-5. doi: 10.1016/j.scr.2018.01.034. Epub 2018 Feb 28.
10
Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson's disease carrying the I2020T mutation in LRRK2.从携带 LRRK2 基因 I2020T 突变的家族性帕金森病 PARK8 患者诱导多能干细胞中生成基因校正的诱导多能干细胞系(KEIUi001-A)。
Stem Cell Res. 2020 Dec;49:102073. doi: 10.1016/j.scr.2020.102073. Epub 2020 Nov 3.